Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

Market ends on a slight upnote after week of poor results
Markets

Market ends on a slight upnote after week of poor results

The reporting season results weighed on the market all week. 

Staff reporters 23 Feb 2024
‘Take a breath’: Greg Foran on Air NZ's year ahead
Markets

‘Take a breath’: Greg Foran on Air NZ's year ahead

Air NZ is carrying some unavoidable lead in the saddlebag for at least the next 18 months.

Pattrick Smellie 23 Feb 2024
Economic headwinds, rail charges hit Port of Tauranga
Infrastructure

Economic headwinds, rail charges hit Port of Tauranga

The biggest export port in the country has reported a drop in net profit. 

Oliver Lewis 23 Feb 2024
NZX's profit slips, trading volumes lowest in nine years
Markets

NZX's profit slips, trading volumes lowest in nine years

But the stock exchange operator's revenue was up.

Riley Kennedy 23 Feb 2024